Conference
Association of immune-related adverse events (irAEs) with clinical benefit in patients with metastatic urothelial carcinoma (mUC) treated with immune-checkpoint inhibitors (ICIs).
Authors
Vitale NP; Pond GR; Abou Alaiwi S; Nassar A; Flippot R; Choueiri TK; Harshman LC; Sonpavde G
Volume
37
Publisher
AMER SOC CLINICAL ONCOLOGY
Publication Date
May 20, 2019
Name of conference
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)
Conference place
Chicago, IL
Conference start date
May 31, 2019
Conference end date
June 4, 2019
Conference proceedings
JOURNAL OF CLINICAL ONCOLOGY
Issue
15
ISSN
0732-183X